CLINICAL_TRIALS
trial_result
· 2017-05-01
Clinical Trial Update: Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis [Phase 3]
Summary
Phase 3 trial update assessing the efficacy and safety of Topoxy 0.25% Desoximetasone Cream for scalp psoriasis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Siriraj Hospital | Conditions: Scalp Psoriasis | Phase 3 | Status: UNKNOWN